Importantly, DSS-treated ApcMin/+;Rbbp9-/- mice exhibited a significantly higher number of colon tumors than identically treated ApcMin/+ mice, accompanied by increased Ki67 and pS6 staining, indicating stronger inflammation-mediated proliferative activity (Figure 5I and J). This evidence concerns the gene RBBP9 and colonic neoplasm.